Eystein Sverre
Husebye
Head of Department
Visit Address:
Haukeland universitetssykehus, Laboratoriebygget
5021 Bergen
Postal Address:
Postboks 7804
5021 Bergen
Phone:
+47 55 97 30 78
E-mail:
Addison's disease
Autoimmune polyendocrine disorders
Hypoparathyroidism
Endocrinology
Journal articles
- 2014. Altered DNA methylation profile in Norwegian patients with Autoimmune Addison's Disease. Molecular Immunology. 59: 208-216. doi: 10.1016/j.molimm.2014.02.018
- 2014. A novel cell-based assay for measuring neutralizing autoantibodies against type I interferons in patients with autoimmune polyendocrine syndrome type 1. Clinical Immunology. 153: 220-227. doi: 10.1016/j.clim.2014.04.013
- 2014. Autoantibodies targeting neurotransmitter biosynthetic enzymes in attention-deficit/hyperactivity disorder (ADHD). European Child and Adolescent Psychiatry. 23: 115-117. doi: 10.1007/s00787-013-0429-3
- 2014. The effect of types I and III interferons on adrenocortical cells and its possible implications for autoimmune Addison's disease. Clinical and Experimental Immunology. 176: 351-362. doi: 10.1111/cei.12291
- 2014. Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency. Journal of Internal Medicine. 275: 104-115. doi: 10.1111/joim.12162
- 2014. Association of autoimmune Addison's disease with alleles of STAT4 and GATA3 in European Cohorts. PLoS ONE. 9. doi: 10.1371/journal.pone.0088991
- 2014. Continuous subcutaneous hydrocortisone infusion versus oral hydrocortisone replacement for treatment of Addison's disease: A randomized clinical trial. Journal of Clinical Endocrinology and Metabolism. 99: 1665-1674. doi: 10.1210/jc.2013-4253
- 2013. Induction of CXCL10 chemokine in adrenocortical cells by stimulation through toll-like receptor 3. Molecular and Cellular Endocrinology. 365: 75-83. doi: 10.1016/j.mce.2012.09.004
- 2013. Autoantibodies against aromatic amino acid hydroxylases in patients with autoimmune polyendocrine syndrome type 1 target multiple antigenic determinants and reveal regulatory regions crucial for enzymatic activity. Immunobiology. 218: 899-909. doi: 10.1016/j.imbio.2012.10.006
- 2013. Characterisation of the CYP21A2 Gene in Patients with Autoimmune Addison's Disease. Scandinavian Journal of Immunology. 77: 310-310.
- 2013. Screening for X-linked adrenoleukodystrophy among adult men with Addison's disease. Clinical Endocrinology. 79: 316-320. doi: 10.1111/cen.12159
- 2013. Anti-cytokine autoantibodies suggest pathogenetic links with autoimmune regulator deficiency in humans and mice. Clinical and Experimental Immunology. 171: 263-272. doi: 10.1111/cei.12024
- 2013. MHC class II association study in eight breeds of dog with hypoadrenocorticism. Immunogenetics. 65: 291-297. doi: 10.1007/s00251-013-0680-2
- 2013. Dominant Inheritance in Autoimmune Endocrine Syndrome Type 1. Scandinavian Journal of Immunology. 77: 306-307.
- 2013. Human leukocyte antigen (DQ2/DQ8) and 21-hydroxylase antibodies determine the thyroid peroxidase antibody status of patients in autoimmune Addison's disease. Experimental and clinical endocrinology & diabetes. 121. 2 pages. doi: 10.1055/s-0033-1336696
- 2013. A candidate gene analysis of canine hypoadrenocorticism in 3 dog breeds. Journal of Heredity. 104: 807-820. doi: 10.1093/jhered/est051
- 2013. BPIFB1 is a lung-specific autoantigen associated with interstitial lung disease. Science Translational Medicine. 5. 10 pages. doi: 10.1126/scitranslmed.3006998
- 2013. Anti-cytokine autoantibodies preceding onset of autoimmune polyendocrine syndrome type I features in early childhood. Journal of Clinical Immunology. 33: 1341-1348. doi: 10.1007/s10875-013-9938-6
- 2012. Mice deficient for the autoimmune regulator, Aire, display altered T cell responses against 21-hydroxylase, the major autoantigen in autoimmune Addison's disease. Immunology. 137: 542-542. doi: 10.1111/imm.12002
- 2012. Radioligand-binding assay reveals distinct autoantibody preferences for type I interferons in APS I and myasthenia gravis subgroups. Journal of Clinical Immunology. 32: 230-237. doi: 10.1007/s10875-011-9617-4
- 2012. Poly (I:C)-induced CXCL10 production in adrenocortical cells - implications for autoimmune Addison's disease? Immunology. 137: 300-301.
- 2012. E. S. Husebye svarer. Tidsskrift for Den norske legeforening. 124: 2475.
- 2012. Nytt steroidkort ved binyrebarksvikt. Tidsskrift for Den norske legeforening. 132: 2043-2044.
- 2012. Autoimmune polyendocrine syndrome Type 1: an Eetensive longitudinal study in Sardinian patients. Journal of Clinical Endocrinology and Metabolism. 97: 1114-1124. doi: 10.1210/jc.2011-2461
- 2012. Genetic, anthropometric and metabolic features of adult Norwegian patients with 21-hydroxylase deficiency. European Journal of Endocrinology. 167: 507-516. doi: 10.1530/EJE-12-0196
- 2012. Measuring autoantibodies against IL-17F and IL-22 in autoimmune polyedocrine sydnrome type I. Immunology. 137: 673-674.
- 2012. Deviant expression of defensins in sera and saliva of patients with autoimmune polyendocrine syndrome type I. Immunology. 137: 211-212.
- 2012. Quality of life in European patients with Addison's Disease: Validity of the disease-specific questionnaire AddiQoL. Journal of Clinical Endocrinology and Metabolism. 97: 568-576. doi: 10.1210/jc.2011-1901
- 2011. Cellular immunity and immunopathology in autoimmune Addison’s disease. Molecular and Cellular Endocrinology. 336: 180-190. doi: 10.1016/j.mce.2010.12.015
- 2011. Genome-wide copy number variation (CNV) in patients with autoimmune Addison's disease. BMC Medical Genetics. 12. 6 pages. doi: 10.1186/1471-2350-12-111
- 2011. Oral manifestations of autoimmune polyendocrine syndrome type I. Caries Research. 45: 186-187. doi: 10.1159/000328514
- 2011. Endogenous Production of CXC Chemokine Ligand 10 (CXCL10) by Adrenocortical Cells and its Implications for Autoimmune Addison's Disease. Scandinavian Journal of Immunology. 73: 371-371.
- 2011. Hypoparathyroidism and autoimmunity in the 22q11.2 deletion syndrome. European Journal of Endocrinology. 165: 345-352. doi: 10.1530/EJE-10-1206
- 2011. Grapefruit juice and licorice increase cortisol availability in patients with Addison's disease. European Journal of Endocrinology. 165: 761-769. doi: 10.1530/EJE-11-0518
- 2011. High frequency of adrenal myelolipomas and testicular adrenal rest tumours in adult Norwegian patients with classical congenital adrenal hyperplasia because of 21-hydroxylase deficiency. Clinical Endocrinology. 75: 753-759. doi: 10.1111/j.1365-2265.2011.04151.x
- 2011. Measuring autoantibodies against IL-17F and IL-22 in Autoimmune Polyendocrine Syndrome Type I by radioligand binding assay using fusion proteins. Scandinavian Journal of Immunology. 74: 327-333. doi: 10.1111/j.1365-3083.2011.02573.x
- 2011. Multiple loci in the HLA complex are associated with Addison's Disease. Journal of Clinical Endocrinology and Metabolism. 96: E1703-E1708. doi: 10.1210/jc.2011-0645
- 2011. TSGA10 – A target for autoantibodies in autoimmune polyendocrine syndrome Type 1 and systemic lupus erythematosus. Scandinavian Journal of Immunology. 73: 147-153. doi: 10.1111/j.1365-3083.2010.02486.x
- 2011. Cytokine Antibodies in Autoimmune Polyendocrine Syndrome Type I Correlates to Chronic candidiasis. Scandinavian Journal of Immunology. 73: 379-379.
- 2010. The Possible Roles of Interferon-Gamma, CXC Chemokine Ligand 10 (CXCL10) and the CXCR3 Circuit in the Pathogenesis of Autoimmune Addison's Disease. Scandinavian Journal of Immunology. 71: 479-480.
- 2010. Acquired Autoimmune Polyglandular Syndrome, Thymoma, and an AIRE Defect. New England Journal of Medicine. 362: 764-766.
- 2010. Sexuality and Fertility in Women with Addison's Disease. Journal of Clinical Endocrinology and Metabolism. 95: 4354-4360. doi: 10.1210/jc.2010-0445
- 2010. Sexuality, Fertility and Androgens in Women with Addison's Disease. Endocrine reviews. 31: 3.
- 2010. Immunoreactivity against kidney collecting ducts in patients with autoimmune polyendocrine syndrome type 1 and systemic hypertension. Endocrine journal. 57: S641-S641.
- 2010. Autoimmune polyendocrine syndromes: clues to type 1 diabetes pathogenesis. Immunity. 32: 479-487. doi: 10.1016/j.immuni.2010.03.016
- 2010. Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. Journal of Experimental Medicine. 207: 299-308. doi: 10.1084/jem.20091669
- 2010. Development of a Disease-Specific Quality of Life Questionnaire in Addison's Disease. Journal of Clinical Endocrinology and Metabolism. 95: 545-551. doi: 10.1210/jc.2009-1711
- 2010. Grapefruit and Liquorice Increase Bioavailable Cortisol in Addison's Disease. Endocrine reviews. 31. 1 pages.
- 2010. Subjective health status in men and women with congenital adrenal hyperplasia: a population-based survey in Norway. European Journal of Endocrinology. 163: 453-459. doi: 10.1530/EJE-10-0284
- 2010. Nucleoporin 62, a Novel Autoantigen in Patients with Autoimmune Polyendocrine Syndrome Type I (APS I). Scandinavian Journal of Immunology. 71: 493-494.
- 2010. A CLEC16A variant confers risk for juvenile idiopathic arthritis and anti-cyclic citrullinated peptide antibody negative rheumatoid arthritis. Annals of the Rheumatic Diseases. 69: 1471-1474. doi: 10.1136/ard.2009.114934
- 2010. Phenotypic Variation in a Large Family with Autosomal Dominant Hypocalcaemia. Hypertension in Pregnancy. 74: 399-405. doi: 10.1159/000303188
- 2010. Novel sequence variation of AIRE and detection of interferon-ω antibodies in early infancy. Clinical Endocrinology. 72: 641-647. doi: 10.1111/j.1365-2265.2009.03740.x
- 2010. Flow cytometry study of blood cell subtypes reflects autoimmune and inflammatory processes in autoimmune polyendocrine syndrome type I. Scandinavian Journal of Immunology. 71: 459-467. doi: 10.1111/j.1365-3083.2010.02397.x
- 2009. Pulmonary autoimmunity as a feature of autoimmune polyendocrine syndrome type 1 and identification of KCNRG as a bronchial autoantigen. Proceedings of the National Academy of Science of the United States of America. 106: 4396-4411. doi: 10.1073/pnas.0809986106
- 2009. The purification and application of biologically active recombinant steroid cytochrome P450 21-hydroxylase: The major autoantigen in autoimmune Addison's disease. Journal of Autoimmunity. 33: 58-67. doi: 10.1016/j.jaut.2009.02.018
- 2009. T Cell Responses to Steroid Cytochrome P450 21-Hydroxylase in Patients with Autoimmune Primary Adrenal Insufficiency. Journal of Clinical Endocrinology and Metabolism. 94: 5117-5124. doi: 10.1210/jc.2009-1115
- 2009. Loss of AIRE Expression in Thymoma Tissue Associated with Multiple Endocrine Autoimmunity: A Novel Case of APS1. Clinical Immunology. 131: S128-S128. doi: 10.1016/j.clim.2009.03.378
- 2009. Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death. European Journal of Endocrinology. 160: 233-237. doi: 10.1530/EJE-08-0550
- 2009. Clinical, Immunological, and Genetic Features of Autoimmune Primary Adrenal Insufficiency: Observations from a Norwegian Registry. Journal of Clinical Endocrinology and Metabolism. 94: 4882-4890. doi: 10.1210/jc.2009-1368
- 2009. Autoantibodies in autoimmune polyglandular syndrome type I patients react with major brain neurotransmitter systems. Journal of Comparative Neurology. 513: 1-20. doi: 10.1002/cne.21913
- 2009. Editorial: Functional Autoantibodies Cause Hypoparathyroidism. Journal of Clinical Endocrinology and Metabolism. 94: 4655-4657. doi: 10.1210/jc.2009-2123
- 2009. Functional autoantibodies cause hypoparathyroidism. Journal of Clinical Endocrinology and Metabolism. 94: 4655-4657.
- 2009. Skin changes as diagnostic aid. Tidsskrift for Den norske legeforening. 129: 752-752. doi: 10.4045/tidsskr.09.0085
- 2009. Immunology of Addison's Disease and premature ovarian failure. Endocrinology and metabolism clinics of North America (Print). 38: 389-405. doi: 10.1016/j.ecl.2009.01.010
- 2009. Pathogenesis of primary adrenal insufficiency. Baillière's Best Practice & Research. Clinical Endocrinology & Metabolism. 23: 147-157. doi: 10.1016/j.beem.2008.09.004
- 2009. Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I. Journal of Internal Medicine. 265: 514-529. doi: 10.1111/j.1365-2796.2009.02090.x
- 2009. Dietary supplementation of tetradecylthioacetic acid increases feed intake but reduces body weight gain and adipose depot sizes in rats fed on high-fat diets. Diabetes, obesity and metabolism. 11: 1034-1049. doi: 10.1111/j.1463-1326.2009.01092.x
- 2009. Development of a Disease-Specific Quality of Life Questionnaire in Addison’s Disease. Journal of Clinical Endocrinology and Metabolism. Published 2009-12-16. doi: 10.1210/jc.2009-1711
- 2009. Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone. European Journal of Endocrinology. 160: 993-1002. doi: 10.1530/EJE-08-0880
- 2009. Tetradecylthioacetic acid attenuates dyslipidaemia in male patients with type 2 diabetes mellitus, possibly by dual PPAR-alpha/delta activation and increased mitochondrial fatty acid oxidation. Diabetes, obesity and metabolism. 11: 304-314. doi: 10.1111/j.1463-1326.2008.00958.x
- 2009. A coding polymorphism in NALP1 confers risk for autoimmune Addison's disease and type 1 diabetes. Genes and Immunity. 10: 120-124. doi: 10.1038/gene.2008.85
- 2009. Programmed death ligand 1 (PD-L1) gene variants contribute to autoimmune Addison's disease and Graves' disease susceptibility. Journal of Clinical Endocrinology and Metabolism. 94: 5139-5145. doi: 10.1210/jc.2009-1404
- 2009. Programmed Death Ligand 1 (PD-L1) Gene Variants Contribute to Autoimmune Addison’s Disease and Graves’ Disease Susceptibility. Journal of Clinical Endocrinology and Metabolism. 94: 5139-5145. doi: 10.1210/jc.2009-1404
- 2009. Two adults with adrenal myelolipoma and 21-hydroxylase deficiency. Clinical Medicine : Case Reports. 4 pages. Published 2009-08-13. doi: 10.1155/2009/916891
- 2009. X-Linked Congenital Adrenal Hypoplasia with Hypogonadotropic Hypogonadism Caused by an Inversion Disrupting a Conserved Noncoding Element Upstream of the NR0B1 (DAX1) Gene. Journal of Clinical Endocrinology and Metabolism. 94: 4086-4093. doi: 10.1210/jc.2009-0923
- 2009. A CLEC16A variant confers risk for juvenile idiopathic arthritis and anti-CCP negative rheumatoid arthritis. Annals of the Rheumatic Diseases. Published 2009-09-01. doi: 10.1136/ard.2009.114934
- 2008. Microarray analysis reveals down-regulation of the tumour suppressor gene WWOX and up-regulation of the oncogene TYMS in intracranial sporadic meningiomas. Journal of Neuro-Oncology. 88: 251-259. doi: 10.1007/s11060-008-9569-6
- 2008. Autoimmune polyendocrine syndrome type 1 and NALP5, parathyroid autoantigen. New England Journal of Medicine. 358: 1018-1028.
- 2008. 21-hydroxylase as a T cell autoantigen in autoimmune Addison's disease. Scandinavian Journal of Immunology. 68: 191-191.
- 2008. Endokrinologisk akuttmedisin. Tidsskrift for Den norske legeforening. 128: 574.
- 2008. Interferon autoantibodies associated with AIRE deficiency decrease the expression of IFN-stimulated genes. Blood. 112: 2657-2666. doi: 10.1182/blood-2008-03-144634
- 2008. Replacement therapy for Addison's disease: recent developments. Expert Opinion on Investigational Drugs. 17: 497-509. doi: 10.1517/13543784.17.4.497
- 2008. Autoimmune polyendocrine syndrome type I in Slovakia: relevance of screening patients with autoimmune Addison's disease. European Journal of Endocrinology. 158: 705-709. doi: 10.1530/EJE-07-0843
- 2008. A coding polymorphism in NALP1 confers risk for autoimmune Addison's disease and type 1 diabetes. Genes and Immunity. doi: 10.1038/gene.2008.85
- 2008. Autoantibodies against Type I Interferons as an Additional Diagnostic Criterion for Autoimmune Polyendocrine Syndrome Type I. Journal of Clinical Endocrinology and Metabolism. 93: 4389-4397. doi: 10.1210/jc.2008-0935
- 2008. Radioimmunoassay for autoantibodies against interferon omega; its use in the diagnosis of autoimmune polyendocrine syndrome type I. Clinical Immunology. 129: 163-169. doi: 10.1016/j.clim.2008.07.002
- 2008. Mutation screening of PTPN22: association of the 1858T-allele with Addison's disease. European Journal of Human Genetics. 16: 977-982. doi: 10.1038/ejhg.2008.33
- 2008. Polymorphisms in CLEC16A and CIITA at 16p13 are associated with primary adrenal insufficiency. Journal of Clinical Endocrinology and Metabolism. 93: 3310-3317. doi: 10.1210/jc.2008-0821
- 2008. AIRE variations in Addison's disease and autoimmune polyendocrine syndromes (APS): partial gene deletions contribute to APS I. Genes and Immunity. 9: 130-136. doi: 10.1038/sj.gene.6364457
- 2007. Pituitary autoantibodies in autoimmune polyendocrine syndrome type 1. Proceedings of the National Academy of Science of the United States of America. 104: 949-954. doi: 10.1073/pnas.0610070104
- 2007. Epitope mapping of human aromatic L-amino acid decarboxylase. Biochemical and Biophysical Research Communications - BBRC. 353: 692-698. doi: 10.1016/j.bbrc.2006.12.080
- 2007. Epitope mapping of human aromatic L-amino acid decarboxylase. Scandinavian Journal of Immunology. 65: 592-592.
- 2007. Continuous subcutaneous hydrocortisone infusion in Addison's disease. European Journal of Endocrinology. 157: 109-112. doi: 10.1530/EJE-07-0052
- 2007. Clinical evolution of Kearns-Sayre syndrome with polyendocrinopathy and respiratory failure. Acta Neurologica Scandinavica. 115: 64-67. doi: 10.1111/j.1600-0404.2007.00850.x
- 2007. Autoimmune polyendocrine syndrome type 1 in Norway: Phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene. Journal of Clinical Endocrinology and Metabolism. 92: 595-603. doi: 10.1210/jc.2006-1873
- 2007. Fc gamma receptor polymorphisms are not associated with autoimmune Addison's disease. Scandinavian Journal of Immunology. 65: 555-558. doi: 10.1111/j.1365-3083.2007.01932.x
- 2006. Detection of autoantibodies to the BTB-kelch protein KLHL7 in cancer sera. Scandinavian Journal of Immunology. 64: 325-335. doi: 10.1111/j.1365-3083.2006.01821.x
- 2006. The substrate-binding domain of 21-hydroxylase, the main autoantigen in autoimmune Addison's disease, is an immunodominant T cell epitope. Endocrinology. 147: 2411-2416. doi: 10.1210/en.2006-0018
- 2006. Saliva cortisol measurement: simple and reliable assessment of the glucocorticoid replacement therapy in Addison's disease. Journal of Endocrinological Investigation. 29: 727-731.
- 2006. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Medicine. 3: 1152-1164. doi: 10.1371/journal.pmed.0030289
- 2005. CTLA4 polymorphisms are associated with vitiligo, in patients with concomitant autoimmune diseases. Pigment Cell Research. 18.
- 2005. CTLA4 polymorphisms are associated with vitiligo, in patients with concomitant autoimmune diseases. Pigment Cell Research. 18: 55-58.
- 2005. Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus. Annals of the Rheumatic Diseases. 64: 210-213. doi: 10.1136/ard.2004.029280
- 2005. Primær binyrebarksvikt - årsaker, diagnostikk og behandling. Tidsskrift for Den norske legeforening. 125: 155-158.
- 2005. Primær binyrebarksvikt - årsaker, diagnostikk og behandling (=Primary adrenal failure - Causes, diagnostics and therapy). Tidsskrift for Den norske legeforening. 125: 155-158.
- 2005. Addison's disease. The Lancet. 365: 2058-2061.
- 2004. Polymorphisms in the cytotoxic T lymphocyte antigen-4 gene region confer susceptibility to Addison's disease. Journal of Clinical Endocrinology and Metabolism. 89: 3474-3476.
- 2004. Pyridoxal phosphatase is a novel cancer autoantigen in the central nervous system. British Journal of Cancer. 91: 1508-1514.
- 2004. Autoantibodies against 21-hydroxylase and side-chain cleavage enzyme in autoimmune Addison's disease are mainly immunoglobulin G1. European Journal of Endocrinology. 150: 49-56.
- 2004. Replacement therapy in Addison's disease. Expert Opinion on Pharmacotherapy. 4: 2145-2149.
- 2004. Chronic mucocutaneous candidiasis and primary hypothyroidism in two families. European Journal of Pediatrics. 163: 604-611.
- 2004. Chronic mucocutaneous candidiasis and primary hypothyroidism in two families. European Journal of Pediatrics. 163: 604-611.
- 2004. Analysis of antibody reactivity against cysteine sulfinic acid decarboxylase, a pyridoxal phosphate-dependent enzyme, in endocrine autoimmune disease. Journal of Clinical Endocrinology and Metabolism. 89: 1636-1640.
- 2004. Paraneoplastic antibodies against HuD detected by a sensitive radiobinding assay. Journal of Neurology. 251: 197-203.
- 2004. Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I. Journal of Clinical Endocrinology and Metabolism. 89: 544-547.
- 2003. Døgnrytme til besvær. Tidsskrift for Den norske legeforening. 123: 1858-1859.
- 2003. Replacement therapy in Addison's disease. Expert Opinion on Pharmacotherapy. 4: 2145-2149.
- 2003. Replacement of Dehydroepiandrosterone in Adrenal Failure: No Benefit for Subjective Healt Status and Sexuality in a 9-Month, Randomized, Parallel Group Clinical Trial. Journal of Clinical Endocrinology and Metabolism. 88: 1112-1118.
- 2003. High frequency of coeliac disease among patients with autoimmune adrenocortical failure. Scandinavian Journal of Gastroenterology. 38: 511-515.
- 2003. Histidine decarboxylase, a pyridoxal phosphate-dependent enzyme, is an autoantigen of gastric enterochromaffin-like cells. Journal of Clinical Endocrinology and Metabolism. 88: 1445-1452.
- 2002. Mutational analysis of the autoimmune regulator gene in sporadic autoimmune Addison`s disease can reveal patients with unidentified autoimmune polyendocrine syndrome type I. European Journal of Endocrinology. 146: 519-522.
- 2002. Autoimmune Regulator and Human Leucocyte Antigen Genotypes as Determinants of the Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy Phenotype. Journal of Clinical Endocrinology and Metabolism. 87: 2568-2574.
- 2002. Hypotyreose. Tidsskrift for Den norske legeforening. 122: 983-983.
- 2002. High prevalence and increasing incidence of Addison's disease in western Norway. Clinical Endocrinology. 56: 787-791.
- 2002. Subjective health status in Norwegian patients with Addison's disease. Clinical Endocrinology. 56: 581-588.
- 2002. Autoimmune adrenocortical failure in Norway. Autoantibodies and HLA class II associations related to clinical features. Journal of Clinical Endocrinology and Metabolism. 87: 618-623.
- 2002. Predictors of outcome and comparison of different drug regimens for the prevention of relapse in patients with Graves' disease. European Journal of Endocrinology. 147: 583-589.
- 2002. Endoscopic ultrasonography for preoperative diagnosis and localization of insulinomas. Scandinavian Journal of Gastroenterology. 37: 732-737.
- 2001. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. American Journal of Human Genetics. 69: 49-54.
- 2001. The transcription factors SOX9 and SOX10 are vitiligo autoantigens in autoimmune polyendocrine syndrome type I. Journal of Biological Chemistry. 276: 35390-35395.
- 2001. Acute adrenal insufficiency--symptoms and treatment. Tidsskrift for Den norske legeforening. 121: 1260.
- 2001. Autoimmune polyendocrine syndrome type 1 (APS I) in Norway. Clinical Endocrinology. 54: 211-217.
- 2000. Pteridin dependent hydroxylases as autoantigens in autoimmune polyendocrine syndrome type 1. Journal of Clinical Endocrinology and Metabolism. 85: 2944-2950.
- 2000. Pteridine-dependent hydroxylases as autoantigens in autoimmune polyendocrine syndrome type 1. Journal of Clinical Endocrinology and Metabolism. 85: 2944-2950.
- 2000. Oral dehydroepiandrosterone (DHEA) replacement therapy in women with Addison's disease. Clinical Endocrinology. 52: 775-780.
- 2000. Oral dehydroepiandrosterone (DHEA) replacement therapy in women with Addison's disease. Clinical Endocrinology. 52: 775-780.
- 2000. Identification of tyrosine hydroxylase as an autoantigen in autoimmune polyendocrine syndrome type I. Biochemical and Biophysical Research Communications - BBRC. 267: 456-461.
- 2000. Identification of tyrosine hydroxylase as an autoantigen in autoimmune polyendocrine syndrome type I. Biochemical and Biophysical Research Communications - BBRC. 267: 456-461.
- 2000. Inhibition of aromatic 1-amino acid decarboxylase by human autoantibodies. Clinical and Experimental Immunology. 120: 420-423.
- 2000. Inhibition of aromatic L-amino acid decarboxylase activity by human autoantibodies. Clinical and Experimental Immunology. 120: 420-423.
- 2000. Autoantibodies against aromatic L-amino acid decarboxylase delineate a subgroup of patients with Addison's disease. Journal of Clinical Endocrinology and Metabolism. 85: 460-463.
- 2000. Autoantibodies against aromatic L-amino acid decarboxylase delineate a subgroup of patients with Addison's disease. Journal of Clinical Endocrinology and Metabolism. 85: 460-463.
- 1999. Antibodies Against Hair Follicles are Associated with Alopecia Totalis in Autoimmune Polyendocrine Syndrome Type I. Journal of Investigative Dermatology. 113: 1054-1058.
- 1998. Identification of tryptophan hydroxylase as an intestinal autoantigen. The Lancet. 352: 279-283.
- 1998. Identification of tryptophan hydroxylase as an intestinal autoantigen. The Lancet. 352: 279-283.
- 1998. Primær binyrebarksvikt - en diagnostisk utfordring. Tidsskrift for Den norske legeforening. 118: 542-544.
- 1998. A cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism is associated with autoimmune Addison's disease in English patients. Clinical Endocrinology. 49: 609-614.
- 1998. Three sisters with Addison's disease. Journal of Clinical Endocrinology and Metabolism. 83: 4204-4206.
- 1998. A family with hereditary extra-adrenal paragangliomas without evidence for mutations in the Von Hippel Lindau disease or ret genes. Clinical Endocrinology. 48: 11-16.
- 1997. Cytochrome P450IA2 and aromatic L-amino acid decarboxylase are hepatic autoantigens in autoimmune polyendocrine syndrome type I. FEBS Letters. 412: 439-445.
- 1997. Autoantibodies against aromatic L-amino acid decarboxylase in autoimmune polyendocrine syndrome type I correlate with the presence of autoimmune hepatitis and vitiligo. Journal of Clinical Endocrinology and Metabolism. 82: 147-150.
- 1997. Chromogranin A and chromogranin B in phaeochromocytoma. European Journal of Endocrinology. 136: 67-73.
Reports and theses
- 2000. Feokromocytom i Neuroindokrine tumorer, en veiledning til diagnostikk og behandling. MANGLER. 2 pages.
- 2000. Feokromocytom i Neuroindokrine tumorer, en veiledning til diagnostikk og behandling. Ukjent, Ukjent. 2 pages.
- 1990. Stimulus-secretion coupling in chromaffin cells of the bovine adrenal medulla : with special reference to the role of phospholipid metabolism. University of Bergen, Department of Biochemistry, Bergen. 1 pages.
Book sections
- 2003. Cushings syndrom. 49-56. In:
- 2003. Livsboka. 151 pages. ISBN: 82-303-0058-5.
More information in national current research information system (CRIStin)
Consultant in endocrinology and internal medicine
Current projects
Co-ordinator of the EU FP7 project Euradrenal